RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma
Authors:
- 13 March 2008
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 15 (13) , 955-965
Abstract
Cell-based vaccination strategies to induce functional tumor-specific T cells in cancer patients have focused on using autologous dendritic cells. An alternative approach is to use RNA-loaded CD40 activated B cells (CD40-B) that are highly efficient antigen-presenting cells capable of priming naive T cells, boosting memory T-cell responses and breaking tolerance to tumor antigens. The use of tumor RNA as the antigenic payload allows for gene transfer without viruses or vectors and permits major histocompatibility complex (MHC)-independent, multiple-antigen targeting. Here, we use CD40L transfected K562 cells to generate functional CD40-B cells from the peripheral blood of humans and dogs. Testing of RNA-loaded CD40-B cells in dogs allows not only for its development in veterinary medicine but also for determination of its safety and efficacy in a large animal model of spontaneous cancer prior to initiation of human clinical trials. We found that CD40-B cells from healthy humans, healthy dogs and tumor-bearing dogs express increased levels of immune molecules such as MHC and CCR7. Moreover, RNA-loaded CD40-B cells induce functional, antigen-specific T cells from healthy dogs and dogs with lymphoma. These findings pave the way for immunotherapy trials using tumor RNA-loaded CD40-B cells to stimulate antitumor immunity in a large animal model of spontaneous neoplasia.Keywords
This publication has 39 references indexed in Scilit:
- Correction of the disease phenotype in canine leukocyte adhesion deficiency using ex vivo hematopoietic stem cell gene therapyBlood, 2006
- Correction of canine X-linked severe combined immunodeficiency by in vivo retroviral gene therapyBlood, 2006
- CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvantsBlood, 2006
- Genome sequence, comparative analysis and haplotype structure of the domestic dogNature, 2005
- Long-Term Restoration of Rod and Cone Vision by Single Dose rAAV-Mediated Gene Transfer to the Retina in a Canine Model of Childhood BlindnessMolecular Therapy, 2005
- Abundance of mRNA of Growth Hormone Receptor and Insulin‐Like Growth Factors‐1 and ‐2 in Duodenal and Colonic Biopsies of Dogs with Chronic Enteropathies*Journal of Veterinary Medicine Series A, 2005
- B‐Lymphocytes Activated by CD40 Ligand Induce an Antigen‐Specific Anti‐Tumour Immune Response by Direct and Indirect Activation of CD8+ T‐cellsScandinavian Journal of Immunology, 2004
- CD40‐dependent and ‐independent activation of human tonsil B cells by CpG oligodeoxynucleotidesEuropean Journal of Immunology, 2003
- Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patientsBlood, 2002
- Cell-mediated and humoral immunity in dogs with spontaneous lymphosarcomaEuropean Journal of Cancer (1965), 1975